HEPA

PINK Hepion Pharmaceuticals, Inc.
Sep 30, 2026 · 3:47 PM ET DELAYED Market Open

$0.1135 ↑ +0.0035 (+3.21%) Trading Up from the previous close of $0.1100, and at the day’s high of $0.1135

YTD change
+89.22%
vs 20-day SMA
+47.22%
vs 200-day SMA
+85.96%

Price ranges

Previous day
$0.0747 $0.1225
open $0.0747 close $0.1100
+$0.0353 (+47.26%)
Today
$0.1000 $0.1135
open $0.1000 now $0.1135
+$0.0135 (+13.53%)
Past week
$0.0486 $0.1225
from $0.0790 now $0.1135
+$0.0345 (+43.71%)
Past month
$0.0486 $0.1225
from $0.0950 now $0.1135
+$0.0185 (+19.51%)
This year
$0.0341 $0.1225
from $0.0600 now $0.1135
+$0.0535 (+89.22%)

Price & Performance

+0.06 (+100.00%) / 6M

$0.0305$0.0590$0.0874$0.1159Mar 30Jun 29Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 100.0% away from all-time highs of $8,350.0000
  • HEPA is up 89% since the beginning of the year
  • HEPA is up 127% over the past 12 months
  • HEPA is up 20% over the past 1 month
  • 0% of all HEPA investors are betting against HEPA

HEPA reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +120.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0771
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.8M
Beta 2.03

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$1.6M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $11.2M

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $423.64 +1.32%
MRNA Moderna, Inc. $203.46 +3.13%
RVMD Revolution Medicines, Inc. $204.48 +1.36%
ROIV Roivant Sciences Ltd. $36.50 -1.30%
BNTX BioNTech SE Sponsored ADR $98.57 -0.51%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.